Compliance, Persistence, Healthcare Resource Use, and Treatment Costs Associated with Aliskiren plus ARB versus ACE Inhibitor plus ARB Combination Therapy: In US Patients with Hypertension

Author： Chang Joanne  

Publisher： Adis International

ISSN： 1175-3277

Source： American Journal of Cardiovascular Drugs, Vol.11, Iss.1, 2011-02, pp. : 21-32

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

ACE inhibitor + ARB therapy: renal toxicity mirrors that seen in RCTs

By  

Reactions Weekly, Vol. 1, Iss. 1347, 2011-01 ,pp. : 3-3

Adis International

Access to resources Recommend Favorite

Zofenopril plus Hydrochlorothiazide: Combination Therapy for the Treatment of Mild to Moderate Hypertension

By Zanchetti Alberto  

Drugs, Vol. 66, Iss. 8, 2006-01 ,pp. : 1107-1115

Adis International

Access to resources Recommend Favorite

Healthcare Costs with Tiotropium Plus Usual Care versus Usual Care Alone Following 1 Year of Treatment in Patients with Chronic Obstructive Pulmonary Disorder (COPD)

By Mitchell Friedman  

PharmacoEconomics, Vol. 22, Iss. 11, 2004-01 ,pp. : 741-749

Adis International

Access to resources Recommend Favorite

Delapril plus Indapamide: A Review of the Combination in the Treatment of Hypertension

By Cavalieri Luca  

Clinical Drug Investigation, Vol. 27, Iss. 6, 2007-01 ,pp. : 367-380

Adis International

Access to resources Recommend Favorite

Aliskiren: A Review of its Use as Monotherapy and as Combination Therapy in the Management of Hypertension

By Duggan Sean T.   Chwieduk Claudine M.   Curran Monique P.  

Drugs, Vol. 70, Iss. 15, 2010-10 ,pp. : 2011-2049

Adis International

Access to resources Recommend Favorite